We are live on
!
Find out more
GT
Glenmede Trust Portfolio holdings
AUM
$20.4B
This Fund
S&P 500
This Quarter
Est. Return
+9.09%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$18.6B
AUM Growth
+$370M
(+2%)
Cap. Flow
-$1.05B
Cap. Flow
% of AUM
-5.64%
Top 10 Holdings %
Top 10 Hldgs %
19.87%
Holding
1,286
New
95
Increased
394
Reduced
580
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$42.1M |
| 2 |
Amazon
AMZN
|
+$37.3M |
| 3 |
Agilent Technologies
A
|
+$34.9M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$34.7M |
| 5 |
Netflix
NFLX
|
+$33.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Progressive
PGR
|
+$132M |
| 2 |
Cencora
COR
|
+$65.6M |
| 3 |
Biogen
BIIB
|
+$53.3M |
| 4 |
Applied Materials
AMAT
|
+$44.9M |
| 5 |
Dollar General
DG
|
+$44.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.39% |
| 2 | Healthcare | 13.06% |
| 3 | Financials | 11.34% |
| 4 | Consumer Discretionary | 9.35% |
| 5 | Industrials | 8.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
951
Kinsale Capital Group
KNSL
$8.43B
| $337K | ﹤0.01% |
2,050
-40
| -2% | -$7.34K |
|
952
NETSCOUT
NTCT
$2.89B
| $337K | ﹤0.01% |
11,987
| – | – |
|
953
iShares Preferred and Income Securities ETF
PFF
$13.2B
| $336K | ﹤0.01% |
8,790
-890
| -9% | -$33.8K |
|
|
MTEM
954
DELISTED
Molecular Templates, Inc.
MTEM
| $336K | ﹤0.01% |
1,778
| – | – |
|
955
Bunge Global
BG
$22.8B
| $335K | ﹤0.01% |
4,229
-97
| -2% | -$7.21K |
|
956
Knight Transportation
KNX
$11.4B
| $335K | ﹤0.01% |
6,980
+11
| +0.2% | +$482 |
|
957
Wayfair
W
$12.5B
| $335K | ﹤0.01% |
+1,065
| New | +$314K |
|
958
Martin Marietta Materials
MLM
$35B
| $334K | ﹤0.01% |
996
-364
| -27% | -$116K |
|
|
CWEN.A
959
DELISTED
Clearway Energy Class A
CWEN.A
| $331K | ﹤0.01% |
12,500
+5,000
| +67% | +$144K |
|
960
Casey's General Stores
CASY
$31.7B
| $328K | ﹤0.01% |
1,520
-1,370
| -47% | -$274K |
|
961
Goldman Sachs Innovate Equity ETF
GINN
$203M
| $328K | ﹤0.01% |
5,740
| – | – |
|
962
Axsome Therapeutics
AXSM
$12.1B
| $324K | ﹤0.01% |
5,735
+60
| +1% | +$4.22K |
|
963
NBT Bancorp
NBTB
$2.79B
| $322K | ﹤0.01% |
8,077
-32
| -0.4% | -$1.18K |
|
964
AptarGroup
ATR
$8.8B
| $318K | ﹤0.01% |
2,245
-28
| -1% | -$3.86K |
|
965
Rio Tinto
RIO
$149B
| $318K | ﹤0.01% |
4,113
-2,099
| -34% | -$172K |
|
966
Middlesex Water
MSEX
$1.08B
| $316K | ﹤0.01% |
4,000
-16
| -0.4% | -$1.21K |
|
|
CMD
967
DELISTED
Cantel Medical Corporation
CMD
| $311K | ﹤0.01% |
3,908
-279,763
| -99% | -$21.8M |
|
968
TFS Financial
TFSL
$5.18B
| $310K | ﹤0.01% |
15,240
| – | – |
|
969
Zscaler
ZS
$24.5B
| $306K | ﹤0.01% |
+1,788
| New | +$355K |
|
970
Magna International
MGA
$18.8B
| $301K | ﹤0.01% |
3,428
+56
| +2% | +$4.55K |
|
|
AZPN
971
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $300K | ﹤0.01% |
+2,079
| New | +$300K |
|
972
AvalonBay Communities
AVB
$27.2B
| $299K | ﹤0.01% |
1,629
-51
| -3% | -$8.92K |
|
973
CRISPR Therapeutics
CRSP
$4.68B
| $299K | ﹤0.01% |
2,463
+7
| +0.3% | +$1.06K |
|
974
Sprott Physical Gold
PHYS
$14.5B
| $299K | ﹤0.01% |
22,380
-9,000
| -29% | -$128K |
|
975
New York Times
NYT
$12.2B
| $297K | ﹤0.01% |
5,881
-92
| -2% | -$4.62K |
|
Similar funds
SLAM
EWA
MIC
P
OSAM
CB
EIM
Glenmede Trust's Q1 2021 Portfolio in Review
As of Q1 2021, Glenmede Trust held 1,286 positions worth $18.6B, up 2% from $18.2B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Glenmede Trust withdrew a net $1.05B in Q1 2021, closing 90 positions and reducing 580 holdings. Its most notable exit was Coherent, an estimated $32.9M position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Glenmede Trust opened a new position in Rollins worth $29.6M.
- Glenmede Trust's largest Q1 2021 buy was Rollins: 860,755 shares worth $29.6M.
- Glenmede Trust added most to State Street SPDR S&P 500 ETF Trust in Q1 2021, an estimated $42.1M increase.
- Glenmede Trust's biggest Q1 2021 reduction was Progressive, cutting an estimated $132M.
- Glenmede Trust fully exited Coherent in Q1 2021, selling an estimated $32.9M.
- Glenmede Trust's ten largest holdings make up 20% of its $18.6B portfolio in Q1 2021.
- Glenmede Trust opened 95 new positions and closed 90 in Q1 2021.
- Glenmede Trust's portfolio value rose 2% quarter-over-quarter to $18.6B.
Based on Glenmede Trust's 13F filing for Q1 2021, filed 18 May 2021.